128 related articles for article (PubMed ID: 28842317)
1. Effective treatment of drug resistant recurrent breast tumors harboring cancer stem-like cells by staurosporine/epirubicin co-loaded polymeric micelles.
Zhang J; Kinoh H; Hespel L; Liu X; Quader S; Martin J; Chida T; Cabral H; Kataoka K
J Control Release; 2017 Oct; 264():127-135. PubMed ID: 28842317
[TBL] [Abstract][Full Text] [Related]
2. Nanomedicines Eradicating Cancer Stem-like Cells in Vivo by pH-Triggered Intracellular Cooperative Action of Loaded Drugs.
Kinoh H; Miura Y; Chida T; Liu X; Mizuno K; Fukushima S; Morodomi Y; Nishiyama N; Cabral H; Kataoka K
ACS Nano; 2016 Jun; 10(6):5643-55. PubMed ID: 27093466
[TBL] [Abstract][Full Text] [Related]
3. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181
[TBL] [Abstract][Full Text] [Related]
4. cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells.
Miyano K; Cabral H; Miura Y; Matsumoto Y; Mochida Y; Kinoh H; Iwata C; Nagano O; Saya H; Nishiyama N; Kataoka K; Yamasoba T
J Control Release; 2017 Sep; 261():275-286. PubMed ID: 28666729
[TBL] [Abstract][Full Text] [Related]
5. Epirubicin-loaded polymeric micelles effectively treat axillary lymph nodes metastasis of breast cancer through selective accumulation and pH-triggered drug release.
Chida T; Miura Y; Cabral H; Nomoto T; Kataoka K; Nishiyama N
J Control Release; 2018 Dec; 292():130-140. PubMed ID: 30391405
[TBL] [Abstract][Full Text] [Related]
6. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles.
Zhang Y; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
Biomaterials; 2012 Jan; 33(2):679-91. PubMed ID: 22019123
[TBL] [Abstract][Full Text] [Related]
7. cRGD peptide-installed epirubicin-loaded polymeric micelles for effective targeted therapy against brain tumors.
Quader S; Liu X; Chen Y; Mi P; Chida T; Ishii T; Miura Y; Nishiyama N; Cabral H; Kataoka K
J Control Release; 2017 Jul; 258():56-66. PubMed ID: 28483513
[TBL] [Abstract][Full Text] [Related]
8. Coencapsulation of epirubicin and metformin in PEGylated liposomes inhibits the recurrence of murine sarcoma S180 existing CD133+ cancer stem-like cells.
Yang Q; Zhang T; Wang C; Jiao J; Li J; Deng Y
Eur J Pharm Biopharm; 2014 Nov; 88(3):737-45. PubMed ID: 25460146
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells.
Ke XY; Lin Ng VW; Gao SJ; Tong YW; Hedrick JL; Yang YY
Biomaterials; 2014 Jan; 35(3):1096-108. PubMed ID: 24183698
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of epirubicin-loaded lipid microbubbles with conjugated anti-ABCG2 antibody combined with therapeutic ultrasound on multiple myeloma cancer stem cells.
Shi F; Yang F; He X; Zhang Y; Wu S; Li M; Zhang Y; Di W; Dou J; Gu N
J Drug Target; 2016; 24(1):34-46. PubMed ID: 26204324
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells.
Hu K; Zhou H; Liu Y; Liu Z; Liu J; Tang J; Li J; Zhang J; Sheng W; Zhao Y; Wu Y; Chen C
Nanoscale; 2015 May; 7(18):8607-18. PubMed ID: 25898852
[TBL] [Abstract][Full Text] [Related]
13. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.
Farnie G; Sotgia F; Lisanti MP
Oncotarget; 2015 Oct; 6(31):30472-86. PubMed ID: 26421710
[TBL] [Abstract][Full Text] [Related]
14. cRGD-installed polymeric micelles loading platinum anticancer drugs enable cooperative treatment against lymph node metastasis.
Makino J; Cabral H; Miura Y; Matsumoto Y; Wang M; Kinoh H; Mochida Y; Nishiyama N; Kataoka K
J Control Release; 2015 Dec; 220(Pt B):783-91. PubMed ID: 26474676
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44⁺ human breast cancer cells.
Croker AK; Allan AL
Breast Cancer Res Treat; 2012 May; 133(1):75-87. PubMed ID: 21818590
[TBL] [Abstract][Full Text] [Related]
16. Effect of combined treatment with the epirubicin-incorporating micelles (NC-6300) and 1,2-diaminocyclohexane platinum (II)-incorporating micelles (NC-4016) on a human gastric cancer model.
Yamamoto Y; Hyodo I; Takigahira M; Koga Y; Yasunaga M; Harada M; Hayashi T; Kato Y; Matsumura Y
Int J Cancer; 2014 Jul; 135(1):214-23. PubMed ID: 24353132
[TBL] [Abstract][Full Text] [Related]
17. Combination of drug-conjugated SWCNT nanocarriers for efficient therapy of cancer stem cells in a breast cancer animal model.
Al Faraj A; Shaik AS; Ratemi E; Halwani R
J Control Release; 2016 Mar; 225():240-51. PubMed ID: 26827662
[TBL] [Abstract][Full Text] [Related]
18. Enhanced antitumor activity and attenuated cardiotoxicity of Epirubicin combined with Paeonol against breast cancer.
Wu J; Xue X; Zhang B; Cao H; Kong F; Jiang W; Li J; Sun D; Guo R
Tumour Biol; 2016 Sep; 37(9):12301-12313. PubMed ID: 27272157
[TBL] [Abstract][Full Text] [Related]
19. Multi-cycle chemotherapy with the glycolipid-like polymeric micelles evade cancer stem cell enrichment in breast cancer therapy.
Meng T; Liu J; Wen L; Yuan M; Cheng B; Hu Y; Zhu Y; Liu X; Yuan H; Hu F
Oncotarget; 2016 Nov; 7(45):72978-72989. PubMed ID: 27659522
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin and lapatinib combination nanomedicine for treating resistant breast cancer.
Wang H; Li F; Du C; Wang H; Mahato RI; Huang Y
Mol Pharm; 2014 Aug; 11(8):2600-11. PubMed ID: 24405470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
